Skip to content

Explant Kit EX-01-K

by Neuropace, Inc.

Explant Kit EX-01-K is a brain-responsive electrical stimulation system (FDA Class III; FDA product code PFN, Implanted Brain Stimulator For Epilepsy) made by Neuropace, Inc., approved under FDA PMA P100026 on 14 Nov 2013 and listed in FDA GUDID since 22 Feb 2022 (UDI-DI 00855547005410), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P100026

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00855547005410 UDI-DI Date22 Feb 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP100026 Date14 Nov 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P100026 decided 14 Nov 2013 Active
  • FDA GUDID UDI-DI 00855547005410 listed 22 Feb 2022 Listed

Timeline

2 dated events

  1. Approved FDA PMA P100026
  2. Listed FDA GUDID 00855547005410

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Explant Kit
Generic name
Brain-responsive electrical stimulation system
Model / reference
EX-01-K
Primary DI / UDI-DI
00855547005410
PMA number
FDA product code
PFN
GMDN term
Brain-responsive electrical stimulation system
Device class
Class III
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional

Other devices from Neuropace, Inc.

See all devices from Neuropace, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Serial number
  • Expiration date
Other properties (9, all answered No)